Clinical trialNCT01604889TerminatedPhase 1/PHASE2Interventional

A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma

SponsorIncyte CorporationEnrollment50Melanoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lance Leopold, M.D.
Incyte Corporation
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Los Angeles, California, United States
Facility name not stated
Miami, Florida, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Chicago, Illinois, United States
Facility name not stated
Durham, North Carolina, United States
Facility name not stated
Philadelphia, Pennsylvania, United States
Facility name not stated
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Mar 2012
Primary completion: 27 Dec 2016
Completion: 20 Jan 2017
Last update posted: 21 Apr 2026
Registered enrollment: 50
Registry id: NCT01604889

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.